Cargando…
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination
The impact of coronavirus disease 2019 vaccination on viral characteristics of breakthrough infections is unknown. In this prospective cohort study, incidence of severe acute respiratory syndrome coronavirus 2 infection decreased following vaccination. Although asymptomatic positive tests were obser...
Autores principales: | North, Crystal M, Barczak, Amy, Goldstein, Robert H, Healy, Brian C, Finkelstein, Dianne M, Ding, Delaney D, Kim, Andy, Boucau, Julie, Shaw, Bennett, Gilbert, Rebecca F, Vyas, Tammy, Reynolds, Zahra, Siddle, Katherine J, MacInnis, Bronwyn L, Regan, James, Flynn, James P, Choudhary, Manish C, Vyas, Jatin M, Laskowski, Karl, Dighe, Anand S, Lemieux, Jacob E, Li, Jonathan Z, Baden, Lindsey R, Siedner, Mark J, Woolley, Ann E, Sacks, Chana A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436402/ https://www.ncbi.nlm.nih.gov/pubmed/34363462 http://dx.doi.org/10.1093/cid/ciab643 |
Ejemplares similares
-
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
por: Siedner, Mark J., et al.
Publicado: (2022) -
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
por: Seaman, Michael S., et al.
Publicado: (2022) -
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
por: Seaman, Michael S., et al.
Publicado: (2022) -
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy
por: Edelstein, Gregory E., et al.
Publicado: (2023) -
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection
por: Boucau, Julie, et al.
Publicado: (2022)